MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project
暂无分享,去创建一个
Jiali Han | J. Little | D. Polsky | F. Sera | S. Gandini | P. Maisonneuve | N. Gruis | D. Lazovich | M. Landi | P. Kanetsky | J. Newton-Bishop | S. Raimondi | P. Ghiorzo | M. Fargnoli | J. García-Borrón | C. Menin | R. Bellocco | E. Tagliabue | J. Little
[1] J. Pearson,et al. Mutation load in melanoma is affected by MC1R genotype , 2017, Pigment cell & melanoma research.
[2] Rajiv Kumar,et al. TERT promoter mutations associate with MC1R variants in melanoma patients , 2017, Pigment cell & melanoma research.
[3] N. Bartolomeo,et al. Detrimental effects of melanocortin‐1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors , 2016, Pigment cell & melanoma research.
[4] S. Puig,et al. Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project. , 2016, The Journal of investigative dermatology.
[5] M. Weinstock,et al. Visual Inspection and the US Preventive Services Task Force Recommendation on Skin Cancer Screening. , 2016, JAMA.
[6] Paula R. Blasi,et al. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.
[7] Tumaini R. Coker,et al. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. , 2023, JAMA.
[8] Nicola D. Roberts,et al. Germline MC1R status influences somatic mutation burden in melanoma , 2016, Nature Communications.
[9] J. D'Orazio,et al. Melanocortin 1 Receptor: Structure, Function, and Regulation , 2016, Front. Genet..
[10] P. Raina,et al. Multigene panels in prostate cancer risk assessment: a systematic review , 2015, Genetics in Medicine.
[11] D. Whiteman,et al. Independent validation of six melanoma risk prediction models. , 2015, The Journal of investigative dermatology.
[12] N. Bartolomeo,et al. Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants , 2015, Archives of Dermatological Research.
[13] Z. Abdel‐Malek,et al. MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation , 2014, Pigment cell & melanoma research.
[14] D. Polsky,et al. Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance , 2014, PloS one.
[15] Jiali Han,et al. MC1R variants increased the risk of sporadic cutaneous melanoma in darker‐pigmented Caucasians: A pooled‐analysis from the M‐SKIP project , 2014, International journal of cancer.
[16] Bruce K Armstrong,et al. Risk prediction models for incident primary cutaneous melanoma: a systematic review. , 2014, JAMA dermatology.
[17] J. Barrett,et al. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study , 2013, BMC Cancer.
[18] J. Ioannidis,et al. Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study , 2013, PloS one.
[19] Linda Valeri,et al. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. , 2013, Psychological methods.
[20] J. Lortet-Tieulent,et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.
[21] B. Dréno,et al. Validation of the Self-Assessment of Melanoma Risk Score for a melanoma-targeted screening , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[22] P. Queirolo,et al. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients , 2012, Experimental dermatology.
[23] T. Dwyer,et al. Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies , 2012, BMC Medical Research Methodology.
[24] J. Fortin,et al. Selected Melanocortin 1 Receptor Single-Nucleotide Polymorphisms Differentially Alter Multiple Signaling Pathways , 2012, Journal of Pharmacology and Experimental Therapeutics.
[25] V. Swope,et al. Alpha-Melanocyte–Stimulating Hormone Suppresses Oxidative Stress through a p53-Mediated Signaling Pathway in Human Melanocytes , 2012, Molecular Cancer Research.
[26] R. Sturm,et al. MC1R variant allele effects on UVR-induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture. , 2012, The Journal of investigative dermatology.
[27] D. Schadendorf,et al. Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study , 2012, Pigment cell & melanoma research.
[28] Peter Kraft,et al. Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[29] Caitlin P. McHugh,et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. , 2011, Human molecular genetics.
[30] N. Hayward,et al. Melanocortin 1 receptor and risk of cutaneous melanoma: A meta‐analysis and estimates of population burden , 2011, International journal of cancer.
[31] John P A Ioannidis,et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. , 2011, Journal of the National Cancer Institute.
[32] S. Tognazzo,et al. Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy , 2011, Pigment cell & melanoma research.
[33] D. English,et al. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact , 2011, Genetic epidemiology.
[34] D. Clayton,et al. The Simpson's paradox unraveled. , 2011, International journal of epidemiology.
[35] M. Gail,et al. Predicting the Future of Genetic Risk Prediction , 2011, Cancer Epidemiology, Biomarkers and Prevention.
[36] Stijn Vansteelandt,et al. Odds ratios for mediation analysis for a dichotomous outcome. , 2010, American journal of epidemiology.
[37] David A. Hinds,et al. Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.
[38] D. Elder,et al. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? , 2010, Cancer.
[39] N. Gruis,et al. Management of Melanoma Families , 2010, Cancers.
[40] J. Malvehy,et al. Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.
[41] D. Elder,et al. MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.
[42] D. Duffy,et al. Red hair is the null phenotype of MC1R , 2008, Human mutation.
[43] F. Sera,et al. MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.
[44] T. Manolio,et al. How to Interpret a Genome-wide Association Study Topic Collections , 2022 .
[45] D. Duffy,et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. , 2007, Human molecular genetics.
[46] G. Barsh,et al. Distinct Pigmentary and Melanocortin 1 Receptor–Dependent Components of Cutaneous Defense against Ultraviolet Radiation , 2006, PLoS genetics.
[47] D. Pinkel,et al. MC1R germline variants confer risk for BRAF-mutant melanoma. , 2006, Science.
[48] K. Wakamatsu,et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. , 2006, Pigment cell research.
[49] P. Carli,et al. Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2006, Journal of the National Cancer Institute.
[50] J. García-Borrón,et al. Melanocortin-1 receptor structure and functional regulation. , 2005, Pigment cell research.
[51] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.
[52] Maria Teresa Landi,et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2005, Journal of the National Cancer Institute.
[53] Andrew N Freedman,et al. Cancer risk prediction models: a workshop on development, evaluation, and application. , 2005, Journal of the National Cancer Institute.
[54] D. Whiteman,et al. A Risk Prediction Tool for Melanoma? , 2005, Cancer Epidemiology Biomarkers & Prevention.
[55] R. Sturm,et al. Novel MC1R variants in Ligurian melanoma patients and controls , 2004, Human mutation.
[56] A. Chompret,et al. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. , 2004, Journal of the National Cancer Institute.
[57] T. Dwyer,et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? , 2004, American journal of epidemiology.
[58] Wei Chen,et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. , 2003, Human molecular genetics.
[59] J. Protheroe. Communicating risk , 2003, BMJ : British Medical Journal.
[60] N. G. Martin,et al. Genetic Association and Cellular Function of MC1R Variant Alleles in Human Pigmentation , 2003, Annals of the New York Academy of Sciences.
[61] F. Collins,et al. A vision for the future of genomics research , 2003, Nature.
[62] R. Willemze,et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.
[63] R. Pill,et al. Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score , 1998, BMJ.
[64] N. Martin,et al. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.
[65] R. Lucas,et al. Validation of Brief Questionnaire Measures of Sun Exposure and Skin Pigmentation Against Detailed and Objective Measures Including Vitamin D Status , 2013, Photochemistry and photobiology.
[66] Jochen K. Lennerz,et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair / fair skin background , 2012 .
[67] J. Hansson. Familial melanoma. , 2008, The Surgical clinics of North America.
[68] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.
[69] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.